MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Irisin as a Molecular Mediator of Exercise Induced Neuroprotection and Disease Modification in Parkinson’s Disease

    NIK. Choudhary (Jodhpur, India)

    Objective: To integrate mechanistic evidence delineating irisin mediated molecular pathways relevant to Parkinson’s disease (PD) pathogenesis and neuroprotection, focusing on α-syn clearance, autophagy–lysosomal function, mitochondrial…
  • 2026 International Congress

    Effectiveness of Acupuncture for Parkinson’s Disease with Mild Cognitive Impairment A Randomized Clinical Trial

    II. Leong, SN. Wu, JQ. Fan, LX. Zhuang (Guangzhou, China)

    Objective: To evaluate the efficacy and safety of acupuncture for PD-MCI, and improve the credibility of acupuncture research evidence through employing a sham acupuncture device…
  • 2026 International Congress

    Predicting Parkinson’s: Navigating Risk, Rights, and Regulation

    J. Braun, B. Schmitz-Luhn (Bonn, Germany)

    Objective: This study explores the legal and ethical challenges surrounding predictive testing for Parkinson’s disease (PD), with a particular focus on its impact in employment,…
  • 2026 International Congress

    Clinical Impact of Nicotine in Parkinson’s Disease: Evidence from Randomized Controlled Studies

    J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)

    Objective: To evaluate the effects of nicotine versus placebo in Parkinson’s disease (PD). Background: Nicotine may influence dopaminergic and non‑dopaminergic pathways relevant to PD. While…
  • 2026 International Congress

    Association of Quality of Life with Risk Markers and Prodromal Signs of Parkinson’s Disease in the Population-Based Healthy Brain Ageing Study

    N. Peña Arauzo, C. Pauly, SR. Jonsdottir, C. Theyer, L. Zamarian, C. Horlings, S. Leiter, W. Poewe, B. Mollenhauer, C. Trenkwalder, S. Schade, R. Krüger, DF. Pilco-Janeta, A. Garrido, F. Farfan, V. Satagopam, S. Ghosh, K. Rege, A. Noyce, P. Mahlknecht (Innsbruck, Austria)

    Objective: To understand which factors associated with the risk of developing Parkinson's disease (PD) influence quality of life (QoL) in a cohort from the European…
  • 2026 International Congress

    Posterior tibial nerve Stimulation in the management of Urinary Disorders in Parkinson’s Disease Experience of the National Hospital Center of Pikine

    F. Niakam M., N. Mundih, M O. Ngoule, A. Ngassaki, SA. Sow, AM. Diop, J. Kahwagi, MD. Dia, C. Kwama, SA. Jouonang, CB. Bangweni, M. Boukoulou, AG. Faye, C. M. Samba, S. Kamali, M. Ndiaye, M. Fall (Dakar, Senegal)

    Objective: Evaluate the efficacy of posterior tibial nerve stimulation in the management of LUTS in patients with PDCompare posterior tibial nerve stimulation to medication Background:…
  • 2026 International Congress

    Enteric Alpha-Synuclein Pathology in Early-Onset Parkinson’s Disease and an Incidental Case in Spinocerebellar Ataxia Type 6

    C. Shin, SI. Kim, SH. Park, JM. Kim, JY. Lee, SJ. Chung, JW. Kim, TB. Ahn, KW. Park, JH. Shin, HY. Lee, SH. Kong, YS. Suh, HJ. Kim, B. Jeon (Seongnam-si, Republic of Korea)

    Objective: This study aimed to investigate Alpha-synuclein (AS) accumulation in the gastrointestinal (GI) tract of patients with early-onset PD (EOPD). Background: AS accumulation is found…
  • 2026 International Congress

    Gut Barrier Failure In Parkinson Disease: Reduced Colonic Resilience In Moderate Disease And Spontaneous Pan-Intestinal Leak In Severe Disease

    M. Abdel-Mohsen, M. Shaikh, L. Zhang, P. Engen, C. Neumann, M. Villanueva, D. Sanchez-Bass, L. Dibenedetto, S. Luo, B. Killinger, C. Soto, S. Green, L. Lagorio, R. Voigt, A. Sharma, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: To determine whether intestinal barrier dysfunction in Parkinson disease (PD) is stage-specific by assessing baseline epithelial permeability and resilience to inflammatory and microbial stressors.…
  • 2026 International Congress

    Evaluating YouTube as a source of health information on Parkinson’s disease

    KJ. Baladjay, LM. Bagares, RD. Jamora (Manila, Philippines)

    Objective: This study aimed to evaluate the quality, reliability, and engagement characteristics of YouTube videos on Parkinson's disease using standardized assessment tools. Background: Parkinson’s disease…
  • 2026 International Congress

    Baseline assessment of nigrostriatal integrity via VMAT2 PET in participants with Parkinson’s disease from the BIIB122/DNL151 LUMA Phase 2b study

    A. Hone-Blanchet, R. Llorens-Arenas, B. Hersh, O. Mabrouk, J. Dubois, D. Jennings, M. Clarke, A. Wittington, M. Wald, D. Graham, M. Hutchison (Cambridge, USA)

    Objective: Evaluate nigrostriatal integrity using vesicular monoamine transporter 2 (VMAT2) PET in participants with early-stage PD enrolled in the LUMA study. Background: LUMA is a…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley